Long

CRISPR - Genetic Improvements

Updated

and
CRISPR-Cas9, -Cas11, -Cas12 genetic improvements for bio-pharma partnerships
The next big thing to improving and repairing defects in you RNA

Currently at Fibretracement 0.618 and in spot to move up or down, depending on big money theory...wahahah!
but there's enough small money to pull it down, just saying for disclosure.

Note

CRISPR just got FDA approval for first clinical trial in gene editing.

Note

Dropping to 786fibretracement at 29.80 or lower. Set alert to 30, 20, and 18. Buying all I can below 20 and easy 10bagger in next decade.

Note

Closing in on 30, watch VIX to dip below 15 for buying flury.

Note

Target entry at 786 retracement and below $30. Expecting no increase in fed rate this week, maybe next. Gov. shutdown looming Friday leaves Fed. shifting as my prognostication.

Pokethebear

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.